1 Transdermal Drug Patches Market Overview 1.1 Product Overview and Scope of Transdermal Drug Patches 1.2 Transdermal Drug Patches Segment by Type 1.2.1 Global Transdermal Drug Patches Market Value Comparison by Type (2023-2029) 1.2.2 Methyl Salicylate-based Patch 1.2.3 Rivastigmine Transdermal Patch 1.2.4 Fentanyl Transdermal Patch 1.2.5 Lidocaine Patch 1.2.6 Diclofenac Patch 1.2.7 Nicotine Transdermal Patch 1.2.8 Others 1.3 Transdermal Drug Patches Segment by Application 1.3.1 Global Transdermal Drug Patches Market Value by Application: (2023-2029) 1.3.2 Rx Channel 1.3.3 OTC Channel 1.4 Global Transdermal Drug Patches Market Size Estimates and Forecasts 1.4.1 Global Transdermal Drug Patches Revenue 2018-2029 1.4.2 Global Transdermal Drug Patches Sales 2018-2029 1.4.3 Global Transdermal Drug Patches Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Transdermal Drug Patches Market Competition by Manufacturers 2.1 Global Transdermal Drug Patches Sales Market Share by Manufacturers (2018-2023) 2.2 Global Transdermal Drug Patches Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Transdermal Drug Patches Average Price by Manufacturers (2018-2023) 2.4 Global Transdermal Drug Patches Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Transdermal Drug Patches, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Transdermal Drug Patches, Product Type & Application 2.7 Transdermal Drug Patches Market Competitive Situation and Trends 2.7.1 Transdermal Drug Patches Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Transdermal Drug Patches Players Market Share by Revenue 2.7.3 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Transdermal Drug Patches Retrospective Market Scenario by Region 3.1 Global Transdermal Drug Patches Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Transdermal Drug Patches Global Transdermal Drug Patches Sales by Region: 2018-2029 3.2.1 Global Transdermal Drug Patches Sales by Region: 2018-2023 3.2.2 Global Transdermal Drug Patches Sales by Region: 2024-2029 3.3 Global Transdermal Drug Patches Global Transdermal Drug Patches Revenue by Region: 2018-2029 3.3.1 Global Transdermal Drug Patches Revenue by Region: 2018-2023 3.3.2 Global Transdermal Drug Patches Revenue by Region: 2024-2029 3.4 North America Transdermal Drug Patches Market Facts & Figures by Country 3.4.1 North America Transdermal Drug Patches Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Transdermal Drug Patches Sales by Country (2018-2029) 3.4.3 North America Transdermal Drug Patches Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Transdermal Drug Patches Market Facts & Figures by Country 3.5.1 Europe Transdermal Drug Patches Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Transdermal Drug Patches Sales by Country (2018-2029) 3.5.3 Europe Transdermal Drug Patches Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Country 3.6.1 Asia Pacific Transdermal Drug Patches Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Transdermal Drug Patches Sales by Country (2018-2029) 3.6.3 Asia Pacific Transdermal Drug Patches Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 China Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.7 Latin America Transdermal Drug Patches Market Facts & Figures by Country 3.7.1 Latin America Transdermal Drug Patches Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Transdermal Drug Patches Sales by Country (2018-2029) 3.7.3 Latin America Transdermal Drug Patches Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country 3.8.1 Middle East and Africa Transdermal Drug Patches Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Transdermal Drug Patches Sales by Country (2018-2029) 3.8.3 Middle East and Africa Transdermal Drug Patches Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Transdermal Drug Patches Sales by Type (2018-2029) 4.1.1 Global Transdermal Drug Patches Sales by Type (2018-2023) 4.1.2 Global Transdermal Drug Patches Sales by Type (2024-2029) 4.1.3 Global Transdermal Drug Patches Sales Market Share by Type (2018-2029) 4.2 Global Transdermal Drug Patches Revenue by Type (2018-2029) 4.2.1 Global Transdermal Drug Patches Revenue by Type (2018-2023) 4.2.2 Global Transdermal Drug Patches Revenue by Type (2024-2029) 4.2.3 Global Transdermal Drug Patches Revenue Market Share by Type (2018-2029) 4.3 Global Transdermal Drug Patches Price by Type (2018-2029) 5 Segment by Application 5.1 Global Transdermal Drug Patches Sales by Application (2018-2029) 5.1.1 Global Transdermal Drug Patches Sales by Application (2018-2023) 5.1.2 Global Transdermal Drug Patches Sales by Application (2024-2029) 5.1.3 Global Transdermal Drug Patches Sales Market Share by Application (2018-2029) 5.2 Global Transdermal Drug Patches Revenue by Application (2018-2029) 5.2.1 Global Transdermal Drug Patches Revenue by Application (2018-2023) 5.2.2 Global Transdermal Drug Patches Revenue by Application (2024-2029) 5.2.3 Global Transdermal Drug Patches Revenue Market Share by Application (2018-2029) 5.3 Global Transdermal Drug Patches Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Hisamitsu Pharmaceutical 6.1.1 Hisamitsu Pharmaceutical Corporation Information 6.1.2 Hisamitsu Pharmaceutical Description and Business Overview 6.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio 6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Novartis 6.3.1 Novartis Corporation Information 6.3.2 Novartis Description and Business Overview 6.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Novartis Transdermal Drug Patches Product Portfolio 6.3.5 Novartis Recent Developments/Updates 6.4 UCB Pharma 6.4.1 UCB Pharma Corporation Information 6.4.2 UCB Pharma Description and Business Overview 6.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio 6.4.5 UCB Pharma Recent Developments/Updates 6.5 Mylan 6.5.1 Mylan Corporation Information 6.5.2 Mylan Description and Business Overview 6.5.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.5.4 Mylan Transdermal Drug Patches Product Portfolio 6.5.5 Mylan Recent Developments/Updates 6.6 Teva Pharmaceutical 6.6.1 Teva Pharmaceutical Corporation Information 6.6.2 Teva Pharmaceutical Description and Business Overview 6.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio 6.6.5 Teva Pharmaceutical Recent Developments/Updates 6.7 Nitto Denko 6.6.1 Nitto Denko Corporation Information 6.6.2 Nitto Denko Description and Business Overview 6.6.3 Nitto Denko Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Nitto Denko Transdermal Drug Patches Product Portfolio 6.7.5 Nitto Denko Recent Developments/Updates 6.8 Grünenthal 6.8.1 Grünenthal Corporation Information 6.8.2 Grünenthal Description and Business Overview 6.8.3 Grünenthal Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.8.4 Grünenthal Transdermal Drug Patches Product Portfolio 6.8.5 Grünenthal Recent Developments/Updates 6.9 IBSA Group 6.9.1 IBSA Group Corporation Information 6.9.2 IBSA Group Description and Business Overview 6.9.3 IBSA Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.9.4 IBSA Group Transdermal Drug Patches Product Portfolio 6.9.5 IBSA Group Recent Developments/Updates 6.10 GSK 6.10.1 GSK Corporation Information 6.10.2 GSK Description and Business Overview 6.10.3 GSK Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.10.4 GSK Transdermal Drug Patches Product Portfolio 6.10.5 GSK Recent Developments/Updates 6.11 Luye Pharma Group 6.11.1 Luye Pharma Group Corporation Information 6.11.2 Luye Pharma Group Transdermal Drug Patches Description and Business Overview 6.11.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.11.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio 6.11.5 Luye Pharma Group Recent Developments/Updates 6.12 Pfizer 6.12.1 Pfizer Corporation Information 6.12.2 Pfizer Transdermal Drug Patches Description and Business Overview 6.12.3 Pfizer Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.12.4 Pfizer Transdermal Drug Patches Product Portfolio 6.12.5 Pfizer Recent Developments/Updates 6.13 Chattem 6.13.1 Chattem Corporation Information 6.13.2 Chattem Transdermal Drug Patches Description and Business Overview 6.13.3 Chattem Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.13.4 Chattem Transdermal Drug Patches Product Portfolio 6.13.5 Chattem Recent Developments/Updates 6.14 Dr Reddy’s Laboratories 6.14.1 Dr Reddy’s Laboratories Corporation Information 6.14.2 Dr Reddy’s Laboratories Transdermal Drug Patches Description and Business Overview 6.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio 6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates 6.15 Bayer 6.15.1 Bayer Corporation Information 6.15.2 Bayer Transdermal Drug Patches Description and Business Overview 6.15.3 Bayer Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.15.4 Bayer Transdermal Drug Patches Product Portfolio 6.15.5 Bayer Recent Developments/Updates 6.16 Mundipharma 6.16.1 Mundipharma Corporation Information 6.16.2 Mundipharma Transdermal Drug Patches Description and Business Overview 6.16.3 Mundipharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.16.4 Mundipharma Transdermal Drug Patches Product Portfolio 6.16.5 Mundipharma Recent Developments/Updates 6.17 Endo International 6.17.1 Endo International Corporation Information 6.17.2 Endo International Transdermal Drug Patches Description and Business Overview 6.17.3 Endo International Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.17.4 Endo International Transdermal Drug Patches Product Portfolio 6.17.5 Endo International Recent Developments/Updates 6.18 Beijing Tide Pharmaceutical 6.18.1 Beijing Tide Pharmaceutical Corporation Information 6.18.2 Beijing Tide Pharmaceutical Transdermal Drug Patches Description and Business Overview 6.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2018-2023) 6.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio 6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Transdermal Drug Patches Industry Chain Analysis 7.2 Transdermal Drug Patches Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Transdermal Drug Patches Production Mode & Process 7.4 Transdermal Drug Patches Sales and Marketing 7.4.1 Transdermal Drug Patches Sales Channels 7.4.2 Transdermal Drug Patches Distributors 7.5 Transdermal Drug Patches Customers 8 Transdermal Drug Patches Market Dynamics 8.1 Transdermal Drug Patches Industry Trends 8.2 Transdermal Drug Patches Market Drivers 8.3 Transdermal Drug Patches Market Challenges 8.4 Transdermal Drug Patches Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Transdermal Drug Patches Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Transdermal Drug Patches Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Transdermal Drug Patches Market Competitive Situation by Manufacturers in 2022 Table 4. Global Transdermal Drug Patches Sales (M Pcs) of Key Manufacturers (2018-2023) Table 5. Global Transdermal Drug Patches Sales Market Share by Manufacturers (2018-2023) Table 6. Global Transdermal Drug Patches Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Transdermal Drug Patches Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Transdermal Drug Patches Average Price (US$/Pc) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Transdermal Drug Patches, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Transdermal Drug Patches, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Transdermal Drug Patches, Product Type & Application Table 12. Global Key Manufacturers of Transdermal Drug Patches, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Transdermal Drug Patches Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Transdermal Drug Patches Sales by Region (2018-2023) & (M Pcs) Table 18. Global Transdermal Drug Patches Sales Market Share by Region (2018-2023) Table 19. Global Transdermal Drug Patches Sales by Region (2024-2029) & (M Pcs) Table 20. Global Transdermal Drug Patches Sales Market Share by Region (2024-2029) Table 21. Global Transdermal Drug Patches Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Transdermal Drug Patches Revenue Market Share by Region (2018-2023) Table 23. Global Transdermal Drug Patches Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Transdermal Drug Patches Revenue Market Share by Region (2024-2029) Table 25. North America Transdermal Drug Patches Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Transdermal Drug Patches Sales by Country (2018-2023) & (M Pcs) Table 27. North America Transdermal Drug Patches Sales by Country (2024-2029) & (M Pcs) Table 28. North America Transdermal Drug Patches Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Transdermal Drug Patches Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Transdermal Drug Patches Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Transdermal Drug Patches Sales by Country (2018-2023) & (M Pcs) Table 32. Europe Transdermal Drug Patches Sales by Country (2024-2029) & (M Pcs) Table 33. Europe Transdermal Drug Patches Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Transdermal Drug Patches Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Transdermal Drug Patches Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Transdermal Drug Patches Sales by Region (2018-2023) & (M Pcs) Table 37. Asia Pacific Transdermal Drug Patches Sales by Region (2024-2029) & (M Pcs) Table 38. Asia Pacific Transdermal Drug Patches Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Transdermal Drug Patches Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Transdermal Drug Patches Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Transdermal Drug Patches Sales by Country (2018-2023) & (M Pcs) Table 42. Latin America Transdermal Drug Patches Sales by Country (2024-2029) & (M Pcs) Table 43. Latin America Transdermal Drug Patches Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Transdermal Drug Patches Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Transdermal Drug Patches Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Transdermal Drug Patches Sales by Country (2018-2023) & (M Pcs) Table 47. Middle East & Africa Transdermal Drug Patches Sales by Country (2024-2029) & (M Pcs) Table 48. Middle East & Africa Transdermal Drug Patches Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Transdermal Drug Patches Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Transdermal Drug Patches Sales (M Pcs) by Type (2018-2023) Table 51. Global Transdermal Drug Patches Sales (M Pcs) by Type (2024-2029) Table 52. Global Transdermal Drug Patches Sales Market Share by Type (2018-2023) Table 53. Global Transdermal Drug Patches Sales Market Share by Type (2024-2029) Table 54. Global Transdermal Drug Patches Revenue (US$ Million) by Type (2018-2023) Table 55. Global Transdermal Drug Patches Revenue (US$ Million) by Type (2024-2029) Table 56. Global Transdermal Drug Patches Revenue Market Share by Type (2018-2023) Table 57. Global Transdermal Drug Patches Revenue Market Share by Type (2024-2029) Table 58. Global Transdermal Drug Patches Price (US$/Pc) by Type (2018-2023) Table 59. Global Transdermal Drug Patches Price (US$/Pc) by Type (2024-2029) Table 60. Global Transdermal Drug Patches Sales (M Pcs) by Application (2018-2023) Table 61. Global Transdermal Drug Patches Sales (M Pcs) by Application (2024-2029) Table 62. Global Transdermal Drug Patches Sales Market Share by Application (2018-2023) Table 63. Global Transdermal Drug Patches Sales Market Share by Application (2024-2029) Table 64. Global Transdermal Drug Patches Revenue (US$ Million) by Application (2018-2023) Table 65. Global Transdermal Drug Patches Revenue (US$ Million) by Application (2024-2029) Table 66. Global Transdermal Drug Patches Revenue Market Share by Application (2018-2023) Table 67. Global Transdermal Drug Patches Revenue Market Share by Application (2024-2029) Table 68. Global Transdermal Drug Patches Price (US$/Pc) by Application (2018-2023) Table 69. Global Transdermal Drug Patches Price (US$/Pc) by Application (2024-2029) Table 70. Hisamitsu Pharmaceutical Corporation Information Table 71. Hisamitsu Pharmaceutical Description and Business Overview Table 72. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 73. Hisamitsu Pharmaceutical Transdermal Drug Patches Product Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates Table 75. Johnson & Johnson Corporation Information Table 76. Johnson & Johnson Description and Business Overview Table 77. Johnson & Johnson Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 78. Johnson & Johnson Transdermal Drug Patches Product Table 79. Johnson & Johnson Recent Developments/Updates Table 80. Novartis Corporation Information Table 81. Novartis Description and Business Overview Table 82. Novartis Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 83. Novartis Transdermal Drug Patches Product Table 84. Novartis Recent Developments/Updates Table 85. UCB Pharma Corporation Information Table 86. UCB Pharma Description and Business Overview Table 87. UCB Pharma Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 88. UCB Pharma Transdermal Drug Patches Product Table 89. UCB Pharma Recent Developments/Updates Table 90. Mylan Corporation Information Table 91. Mylan Description and Business Overview Table 92. Mylan Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 93. Mylan Transdermal Drug Patches Product Table 94. Mylan Recent Developments/Updates Table 95. Teva Pharmaceutical Corporation Information Table 96. Teva Pharmaceutical Description and Business Overview Table 97. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 98. Teva Pharmaceutical Transdermal Drug Patches Product Table 99. Teva Pharmaceutical Recent Developments/Updates Table 100. Nitto Denko Corporation Information Table 101. Nitto Denko Description and Business Overview Table 102. Nitto Denko Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 103. Nitto Denko Transdermal Drug Patches Product Table 104. Nitto Denko Recent Developments/Updates Table 105. Grünenthal Corporation Information Table 106. Grünenthal Description and Business Overview Table 107. Grünenthal Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 108. Grünenthal Transdermal Drug Patches Product Table 109. Grünenthal Recent Developments/Updates Table 110. IBSA Group Corporation Information Table 111. IBSA Group Description and Business Overview Table 112. IBSA Group Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 113. IBSA Group Transdermal Drug Patches Product Table 114. IBSA Group Recent Developments/Updates Table 115. GSK Corporation Information Table 116. GSK Description and Business Overview Table 117. GSK Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 118. GSK Transdermal Drug Patches Product Table 119. GSK Recent Developments/Updates Table 120. Luye Pharma Group Corporation Information Table 121. Luye Pharma Group Description and Business Overview Table 122. Luye Pharma Group Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 123. Luye Pharma Group Transdermal Drug Patches Product Table 124. Luye Pharma Group Recent Developments/Updates Table 125. Pfizer Corporation Information Table 126. Pfizer Description and Business Overview Table 127. Pfizer Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 128. Pfizer Transdermal Drug Patches Product Table 129. Pfizer Recent Developments/Updates Table 130. Chattem Corporation Information Table 131. Chattem Description and Business Overview Table 132. Chattem Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 133. Chattem Transdermal Drug Patches Product Table 134. Chattem Recent Developments/Updates Table 135. Dr Reddy’s Laboratories Corporation Information Table 136. Dr Reddy’s Laboratories Description and Business Overview Table 137. Dr Reddy’s Laboratories Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 138. Dr Reddy’s Laboratories Transdermal Drug Patches Product Table 139. Dr Reddy’s Laboratories Recent Developments/Updates Table 140. Bayer Corporation Information Table 141. Bayer Description and Business Overview Table 142. Bayer Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 143. Bayer Transdermal Drug Patches Product Table 144. Bayer Recent Developments/Updates Table 145. Mundipharma Corporation Information Table 146. Mundipharma Description and Business Overview Table 147. Mundipharma Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 148. Mundipharma Transdermal Drug Patches Product Table 149. Mundipharma Recent Developments/Updates Table 150. Endo International Corporation Information Table 151. Endo International Description and Business Overview Table 152. Endo International Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 153. Endo International Transdermal Drug Patches Product Table 154. Endo International Recent Developments/Updates Table 155. Beijing Tide Pharmaceutical Corporation Information Table 156. Beijing Tide Pharmaceutical Description and Business Overview Table 157. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2018-2023) Table 158. Beijing Tide Pharmaceutical Transdermal Drug Patches Product Table 159. Beijing Tide Pharmaceutical Recent Developments/Updates Table 160. Key Raw Materials Lists Table 161. Raw Materials Key Suppliers Lists Table 162. Transdermal Drug Patches Distributors List Table 163. Transdermal Drug Patches Customers List Table 164. Transdermal Drug Patches Market Trends Table 165. Transdermal Drug Patches Market Drivers Table 166. Transdermal Drug Patches Market Challenges Table 167. Transdermal Drug Patches Market Restraints Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Transdermal Drug Patches Figure 2. Global Transdermal Drug Patches Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Transdermal Drug Patches Market Share by Type in 2022 & 2029 Figure 4. Methyl Salicylate-based Patch Product Picture Figure 5. Rivastigmine Transdermal Patch Product Picture Figure 6. Fentanyl Transdermal Patch Product Picture Figure 7. Lidocaine Patch Product Picture Figure 8. Diclofenac Patch Product Picture Figure 9. Nicotine Transdermal Patch Product Picture Figure 10. Others Product Picture Figure 11. Global Transdermal Drug Patches Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 12. Global Transdermal Drug Patches Market Share by Application in 2022 & 2029 Figure 13. Rx Channel Figure 14. OTC Channel Figure 15. Global Transdermal Drug Patches Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Transdermal Drug Patches Market Size (2018-2029) & (US$ Million) Figure 17. Global Transdermal Drug Patches Sales (2018-2029) & (M Pcs) Figure 18. Global Transdermal Drug Patches Average Price (US$/Pc) & (2018-2029) Figure 19. Transdermal Drug Patches Report Years Considered Figure 20. Transdermal Drug Patches Sales Share by Manufacturers in 2022 Figure 21. Global Transdermal Drug Patches Revenue Share by Manufacturers in 2022 Figure 22. The Global 5 and 10 Largest Transdermal Drug Patches Players: Market Share by Revenue in 2022 Figure 23. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 24. Global Transdermal Drug Patches Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 25. North America Transdermal Drug Patches Sales Market Share by Country (2018-2029) Figure 26. North America Transdermal Drug Patches Revenue Market Share by Country (2018-2029) Figure 27. U.S. Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. Canada Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. Europe Transdermal Drug Patches Sales Market Share by Country (2018-2029) Figure 30. Europe Transdermal Drug Patches Revenue Market Share by Country (2018-2029) Figure 31. Germany Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. France Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 33. U.K. Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Italy Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Russia Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. Asia Pacific Transdermal Drug Patches Sales Market Share by Region (2018-2029) Figure 37. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region (2018-2029) Figure 38. China Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Japan Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. South Korea Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. India Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Australia Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. China Taiwan Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Indonesia Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 45. Thailand Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 46. Malaysia Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Latin America Transdermal Drug Patches Sales Market Share by Country (2018-2029) Figure 48. Latin America Transdermal Drug Patches Revenue Market Share by Country (2018-2029) Figure 49. Mexico Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Brazil Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 51. Argentina Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country (2018-2029) Figure 53. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country (2018-2029) Figure 54. Turkey Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 55. Saudi Arabia Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 56. UAE Transdermal Drug Patches Revenue Growth Rate (2018-2029) & (US$ Million) Figure 57. Global Sales Market Share of Transdermal Drug Patches by Type (2018-2029) Figure 58. Global Revenue Market Share of Transdermal Drug Patches by Type (2018-2029) Figure 59. Global Transdermal Drug Patches Price (US$/Pc) by Type (2018-2029) Figure 60. Global Sales Market Share of Transdermal Drug Patches by Application (2018-2029) Figure 61. Global Revenue Market Share of Transdermal Drug Patches by Application (2018-2029) Figure 62. Global Transdermal Drug Patches Price (US$/Pc) by Application (2018-2029) Figure 63. Transdermal Drug Patches Value Chain Figure 64. Transdermal Drug Patches Production Process Figure 65. Channels of Distribution (Direct Vs Distribution) Figure 66. Distributors Profiles Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Hisamitsu Pharmaceutical Johnson & Johnson Novartis UCB Pharma Mylan Teva Pharmaceutical Nitto Denko Grünenthal IBSA Group GSK Luye Pharma Group Pfizer Chattem Dr Reddy’s Laboratories Bayer Mundipharma Endo International Beijing Tide Pharmaceutical